Catheters: Latest News, Top Stories & Analysis

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced findings from a new multinational study demonstrating the efficacy of its Arrow™ Chlorhexidine-Impregnated Central Venous Catheters (CVCs) in reducing central line-associated …

Public Companies

Teleflex Secures Contract with Vizient to Supply Vascular Access Products

January 10, 2025January 10, 2025 - by Timothy Alexander

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced a new contract with Vizient, Inc., the nation’s largest healthcare performance improvement company. Effective January 1, 2025, the agreement grants Vizient’s members …